Seth focuses his practice on intellectual property protection, licensing, strategy, and disputes, as well as research transactions and operations, particularly in life sciences and healthcare. He handles a range of technology and clinical research matters, and advises technology transfer programs at academic and healthcare institutions. Seth also acts as outside general counsel to technology-driven companies. He is the leader of the firm’s Intellectual Property practice and co-chair of the firm’s Life Sciences practice.
I support tech transfer programs at universities, research institutes and academic medical centers. My experience includes patent procurement and portfolio management, coordinating complex research arrangements, negotiating commercial transactions involving IP, resolving related disputes and coordinating IP enforcement activities. I also advise on the development and expansion of tech transfer programs; the operation of incubators, accelerators, and venture funds; and the revision of institutional IP policies to reflect contemporary tech transfer issues. I am intimately familiar with tech transfer operations and the unique environment in which these programs exist.
I represent academic and healthcare institutions and life sciences companies in technology and research-driven transactions. I also work with companies in the private sector that do business with these institutions. My work in this area includes drafting and negotiating license agreements, joint research and development agreements, clinical trial agreements, sponsored research agreements, consulting agreements, and a range of other corporate transactions to effectuate deals in the arenas of research, healthcare, and IP.
I serve as outside general counsel to emerging growth and mid-stage life sciences companies, supporting their businesses in this complex ecosystem. Coordinating with other specialists at the firm when needed, I guide our clients’ fundraising efforts, intellectual property strategy, partnering deals, board governance matters, and their full range of operational issues.
Technology transfer programs at universities and research institutions continue to evolve, deploying a growing range of programs and services to support the development and commercialization of academic innovations.
District of Columbia
U.S. Court of Appeals, Federal Circuit
U.S. Court of Appeals, Ninth Circuit
U.S. District Court, Central District of California
U.S. District Court, Northern District of California
U.S. District Court, District of Idaho
U.S. Patent and Trademark Office
Cornell University, B.S., Agricultural & Biological Engineering, cum laude
University of Southern California Law School, J.D.
Los Angeles patents partner Seth Levy discusses the current state of case law in the U.S., the U.S. Supreme Court's Myriad decision and its aftermath, USPTO Guidance, and patent prosecution tips.
An NP team led by Los Angeles Intellectual Property partners Seth Levy and Shawn Hansen on Monday expanded its groundbreaking patent enforcement campaign on behalf of the Regents of the University of California (UC). The following articles cover the new complaint, filed with the U.S. International Trade Commission, which seeks an investigation into the unauthorized importation and sale after importation of UC’s patented filament LED lighting technology by General Electric, Savant Systems, Feit Electric, Home Depot, Ikea, and Satco Products.
In addition to Seth and Shawn, the NP team includes Washington, DC Intellectual Property partner Evan Langdon; Los Angeles Intellectual Property partners Staci Riordan, Vincent Yip and Peter Wied, and associate Vince Capati; Chicago Intellectual Property associates Paulina Starostka and Angelo Christopher; San Francisco Complex Commercial Disputes associate Tracy Ickes; and Los Angeles patent specialist Jason Moore.
Life Sciences practice co-chair and Los Angeles Intellectual Property partner Seth Levy provides third-party commentary on sovereign immunity for disputes involving patents owned by state universities, after the University of Texas lost an appeal to review a ruling preventing it from using sovereign immunity to shield patents from inter partes reviews.
Subscribe to stay informed of the latest legal news, alerts, and business trends.Subscribe